Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prime Medicine, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 3.14 · gapped below the open, then crossed back over prior close. High/low 3.20 at 1:45 pm ET, 3.02 at 10:45 am ET.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“Under our license and collaboration agreement with Beam, or the Beam Collaboration Agreement, each party grants to the other certain exclusive and non-exclusive licenses and rights to certain Prime Editing, CRISPR and delivery technologies for use in certain specified fields.”
FILING10-K0001628280-26-013569cik 0001894562
“Our compensation committee has engaged Alpine Rewards, LLC, or Alpine Rewards, as its independent compensation consultant.”
FILING10-K0001628280-26-013569cik 0001894562
“Under the amended Broad License Agreement and the 2022 Broad License Agreement, Broad Institute grants us certain rights and licenses under certain patent rights it owns or controls relating to our Prime Editing technology and product candidates.”
FILING10-K0001628280-26-013569cik 0001894562
“Dr. Liu's laboratory at Broad Institute developed engineered pegRNAs, or epegRNAs, which we have exclusively in-licensed.”
FILING10-K0001628280-26-013569cik 0001894562
“Jefferies is not required to sell any specific share amounts but acts as our sales agent, using commercially reasonable efforts consistent with its normal trading and sales practices.”
FILING10-K0001628280-26-013569cik 0001894562
“Pursuant to an advisory services agreement with Jeffrey Marrazzo, a member of our board of directors, or the Marrazzo Agreement, dated February 29, 2024, Mr. Marrazzo agreed to provide certain professional services to the Company separate from and in addition to his service as a member of our board of directors, and we agreed to pay Mr. Marrazzo an annual fee of $50,000 per year in addition to the grant of an option to purchase 250,000 shares of the Company's common stock.”
FILING10-K0001628280-26-013569cik 0001894562
“PricewaterhouseCoopers LLP, or PwC, served as independent registered public accounting firm for our Company with respect to the audit of the Company's consolidated financial statements for the fiscal year ended December 31, 2025”
FILING10-K0001628280-26-013569cik 0001894562
“We have entered into a collaboration and license agreement with Beam, under which we grant Beam certain exclusive and non-exclusive rights in our Prime Editing technology in certain fields.”
FILING10-K0001628280-26-013569cik 0001894562
“In September 2024, we entered into a stock purchase agreement with BMS, or the BMS Purchase Agreement, pursuant to which we agreed to issue and sell, and BMS agreed to purchase, 11,006,163 shares of our common stock, or the BMS Shares, for an aggregate purchase price of $55.0 million pursuant to the terms and conditions thereof.”
FILING10-K0001628280-26-013569cik 0001894562
“In July 2025, Dr. Duffield entered into the Duffield Consulting Agreement with us, pursuant to which Dr. Duffield will provide advice and assistance in the area of his expertise.”
FILING10-K0001628280-26-013569cik 0001894562
“In May 2025, pursuant to the Gottesdiener Separation Agreement and Gottesdiener Employment Agreement, we entered into an advisory services agreement with Dr. Gottesdiener, or the Gottesdiener Advisor Agreement, to retain certain non-exclusive, limited consulting and advisory services of Dr. Gottesdiener for a period of up to one year from the date of his separation.”
FILING10-K0001628280-26-013569cik 0001894562
“In May 2025, pursuant to the Gottesdiener Separation Agreement and Gottesdiener Employment Agreement, we entered into a consulting agreement with KMG Strategic Consulting, LLC, or the KMG Consulting Agreement, a limited liability company managed by Dr. Gottesdiener, to provide for Dr. Gottesdiener's continued consulting services to us.”
FILING10-K0001628280-26-013569cik 0001894562
“• $12.0 million of proceeds received under the CFF Agreement.”
FILING10-K0001628280-26-013569cik 0001894562
Watchlist prices, news filtered to it, and its next report on your desk.
Prime Medicine, Inc. has 10 disclosed suppliers and 3 disclosed customers. Each one is named in an SEC filing, either Prime Medicine, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
PRME (Prime Medicine, Inc.) has 10 disclosed suppliers and 3 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: BEAM −3.73%, in healthcare.